Economic evaluation of screening for open-angle glaucoma.

International Journal of Technology Assessment in Health Care
Rodolfo HernándezOAG Screening Project Group

Abstract

The aim of this study was to assess the cost-effectiveness of screening for open-angle glaucoma (OAG) in the United Kingdom, given that OAG is an important cause of blindness worldwide. A Markov model was developed to estimate lifetime costs and benefits of a cohort of patients facing, alternatively, screening or current opportunistic case finding strategies. Strategies, varying in how screening would be organized (e.g., invitation for assessment by a glaucoma-trained optometrist [GO] or for simple test assessment by a technician) were developed, and allowed for the progression of OAG and treatment effects. Data inputs were obtained from systematic reviews. Deterministic and probabilistic sensitivity analyses were performed. Screening was more likely to be cost-effective as prevalence increased, for 40 year olds compared with 60 or 75 year olds, when the re-screening interval was greater (10 years), and for the technician strategy compared with the GO strategy. For each age cohort and at prevalence levels of < or =1 percent, the likelihood that either screening strategy would be more cost-effective than current practice was small. For those 40 years of age, "technician screening" compared with current practice has an incrementa...Continue Reading

References

Nov 15, 1991·American Journal of Epidemiology·J M TielschA Sommer
Jan 1, 1991·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·M W Tuck
Oct 1, 1966·The British Journal of Ophthalmology·F C Hollows, P A Graham
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Aug 1, 1995·Australian and New Zealand Journal of Ophthalmology·C Jackson, L Hirst
Mar 8, 1998·PharmacoEconomics·A Briggs, M Sculpher
Jul 26, 2003·Clinical & Experimental Ophthalmology·Anne J LeePaul Mitchell
Aug 20, 2004·The British Journal of Ophthalmology·D P CrabbA C Viswanathan
Sep 14, 2004·Health Technology Assessment : HTA·Z PhilipsJ Glanville
Jul 5, 2005·BMJ : British Medical Journal·Philip C MaierYngve T Falck-Ytter
Sep 20, 2005·The British Journal of Ophthalmology·V GuptaK S Kapoor
Feb 8, 2006·PharmacoEconomics·Catherine Meads, Chris Hyde
Feb 21, 2006·The British Journal of Ophthalmology·H A Quigley, A T Broman
Oct 28, 2006·PharmacoEconomics·Milton C Weinstein
Jun 1, 2007·The British Journal of Ophthalmology·A Azuara-BlancoS McPherson
Jul 28, 2007·Acta Ophthalmologica Scandinavica·Hanna Vaahtoranta-LehtonenAntti Malmivaara
Aug 19, 2007·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Jennifer M BurrMandy Ryan

❮ Previous
Next ❯

Citations

May 9, 2012·International Journal of Technology Assessment in Health Care·Suvi MäklinRisto P Roine
Apr 23, 2011·BMC Medical Research Methodology·UNKNOWN Glaucoma screening Platform Study groupLuke D Vale
Aug 6, 2011·BMC Ophthalmology·Fiona C GlenDavid F Garway-Heath
Sep 8, 2010·Ophthalmology·Eugenio A Maul, Henry D Jampel
Feb 7, 2013·Acta Ophthalmologica·Sabina Andersson Geimer
Jan 25, 2012·Acta Ophthalmologica·Margriet M de VriesNomdo M Jansonius
Oct 4, 2013·Journal of Health Services Research & Policy·Jennifer BurrLuke Vale
Oct 25, 2016·BMC Health Services Research·Trishal Boodhna, David P Crabb
Mar 14, 2017·Ophthalmic Epidemiology·Elizabeth HoldsworthWendy Macdowall
Jan 6, 2018·Journal of Global Health·Peige SongKit Yee Chan
Jul 3, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C HirneissA S Neubauer
Feb 26, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C HirneissA S Neubauer
Jul 3, 2019·Health Technology Assessment : HTA·Gus GazzardMarta Buszewicz
Apr 30, 2014·Journal of Glaucoma·Jean-Claude MwanzaPradeep Y Ramulu
Jan 7, 2020·Current Opinion in Ophthalmology·Nicholas Y Q TanChelvin C A Sng
Jan 10, 2021·The British Journal of Ophthalmology·Sujani ShroffDavid S Friedman
Dec 5, 2020·The Lancet Global Health·UNKNOWN GBD 2019 Blindness and Vision Impairment Collaborators, UNKNOWN Vision Loss Expert Group of the Global Burden of Disease Study
Sep 1, 2014·Journal of Current Glaucoma Practice·Sharmila RajendrababuS R Krishnadas
Dec 3, 2021·Health Technology Assessment : HTA·Anthony J KingGraeme MacLennan
Dec 23, 2021·Ophthalmology·Steven J GeddeUNKNOWN American Academy of Ophthalmology Preferred Practice Pattern Glaucoma Panel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.